Cargando…

MYL2 as a potential predictive biomarker for rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is a common malignant soft tissue sarcoma, which is the third most common soft tissue sarcoma after malignant fibrohistoma and liposarcoma. The discovery of potential postbiomarkers could lead to early and more effective treatment measures to reduce the mortality of RMS. The d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Junning, Gao, Shang, Dong, Keqin, Guo, Peiyuan, Shan, Meng-jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483830/ https://www.ncbi.nlm.nih.gov/pubmed/34596111 http://dx.doi.org/10.1097/MD.0000000000027101

Ejemplares similares

MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma
por: Chen, Zihang, et al.
Publicado: (2021)

Single-cell transcriptional profiling reveals the heterogeneity in embryonal rhabdomyosarcoma
por: Hong, Bo, et al.
Publicado: (2021)

Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report
por: Sun, Xiaogang, et al.
Publicado: (2023)

Perianal rhabdomyosarcoma in an adult: A case report and review of the literature
por: Yang, Ning, et al.
Publicado: (2023)

An uncommon perineal embryonal rhabdomyosarcoma in adult: A case report
por: Qu, Sifeng, et al.
Publicado: (2022)

Survival and prognostic analysis of preoperative indicators in patients undergoing surgical resections with rhabdomyosarcoma
por: Jin, Hongyu, et al.
Publicado: (2020)

CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study
por: Luo, Taobo, et al.
Publicado: (2016)

Primary Renal Rhabdomyosarcoma in an Adolescent With Tumor Thrombosis in the Inferior Vena Cava and Right Atrium: A Case Report and Review of the Literature
por: Lin, Wei-Ching, et al.
Publicado: (2016)

The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: Zhang, Chunyi, et al.
Publicado: (2021)

Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?
por: Demirci, Nebi Serkan, et al.
Publicado: (2023)

CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report
por: Jiang, Chiyi, et al.
Publicado: (2019)

Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol
por: Miyachi, Mitsuru, et al.
Publicado: (2019)

Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening
por: Xu, Hang, et al.
Publicado: (2015)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis
por: Yang, Dinglong, et al.
Publicado: (2021)

Serum REG Iα as a potential novel biomarker in cancer: An observational study
por: Zhang, Yumin, et al.
Publicado: (2020)

Katanin subunits p60 and p80, potential biomarkers for papillary thyroid carcinoma to distinguish nodular goiter: STROBE
por: Wu, Zhangming, et al.
Publicado: (2022)

Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology
por: Meng, Zhuo, et al.
Publicado: (2023)

HIST3H2A is a potential biomarker for pancreatic cancer: A study based on TCGA data
por: Zhao, Mengyu, et al.
Publicado: (2021)

Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation
por: Wang, Xikai, et al.
Publicado: (2021)

Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis
por: Peng, Jin-lin, et al.
Publicado: (2021)

LINC01589 serves as a potential tumor-suppressor and immune-related biomarker in endometrial cancer: A review
por: Chen, Ruixin, et al.
Publicado: (2023)

Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors
por: Chen, Kegong, et al.
Publicado: (2021)

Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis
por: Mi, Jing-Lin, et al.
Publicado: (2020)

Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma
por: Li, Xin, et al.
Publicado: (2021)

KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry
por: Gong, Yuqi, et al.
Publicado: (2022)

The exploration of new biomarkers for oral cancer through the ceRNA network and immune microenvironment analysis
por: Ma, Sai, et al.
Publicado: (2022)

MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis
por: Chen, Li, et al.
Publicado: (2021)

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma
por: He, Xiao, et al.
Publicado: (2019)

DWI as a Quantitative Biomarker in Predicting Chemotherapeutic Efficacy at Multitime Points on Gastric Cancer Lymph Nodes Metastases
por: Zhong, Jinman, et al.
Publicado: (2016)

Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development
por: Shang, Xingchen, et al.
Publicado: (2016)

Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study
por: Ge, Lina, et al.
Publicado: (2021)

P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA
por: Tang, Yin, et al.
Publicado: (2017)

Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer: A retrospective study
por: Gao, Jie, et al.
Publicado: (2021)

A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis
por: Wang, Xiao-Wei, et al.
Publicado: (2021)

D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy
por: Go, Se-Il, et al.
Publicado: (2015)

Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker
por: Chen, Lingyun, et al.
Publicado: (2023)

A predictive model to estimate the pretest probability of metastasis in patients with osteosarcoma
por: Wang, Sisheng, et al.
Publicado: (2017)

CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2021)

Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer
por: Yu, Yiwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qimknteqg7m6hs50n769v33go1